Mary Kay Fenton Cullinan Oncology, Inc. (CGEM) insider trading activity

CGEM Quotes by TradingView

Mary Kay Fenton is Chief Financial Officer of Cullinan Oncology, Inc.. Currently has a direct ownership of 60,000 shares of CGEM, which is worth approximately $522,600. The most recent transaction as insider was on Feb 19, 2025, when has been sold 60,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60K
n/a 3M change
n/a 12M change
Total Value Held $522,600

Mary Kay Fenton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 19 2025
BUY
Grant, award, or other acquisition
-
60,000 Added 50.0%
60,000 Common Stock

Also insider at

ONCR
Oncorus, Inc. Healthcare
Director
TALS
Talaris Therapeutics, Inc. Healthcare
Chief Financial Officer
MKF

Mary Kay Fenton

Chief Financial Officer
Wellesley, MA

Track Institutional and Insider Activities on CGEM

Follow Cullinan Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

News

Receive news related to Cullinan Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CGEM